Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

560
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
560
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

93
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

185
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
185
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630
Pharmacovigilance01:19

Pharmacovigilance

833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
  1. Home
  3. Research Domains
  5. Chemical Sciences
  7. Inorganic Chemistry
  9. Inorganic Chemistry Not Elsewhere Classified
  11. Allopurinol Hypersensitivity Syndrome Raising Awareness Of An Uncommon But Potentially Serious Adverse Event Among Kidney Stone Patients

Allopurinol hypersensitivity syndrome Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients

Tariq Alotaibi1, Jennifer Bjazevic1, Richard Kim2

  • 1Division of Urology, Department of Surgery, Schulich School of Medicine and Dentistry, London, ON, Canada.

Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|February 6, 2024

Related Experiment Videos

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.6K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.1K

View abstract on PubMed

Summary
This summary is machine-generated.

Allopurinol is used to prevent urinary stones but can cause serious side effects like Allopurinol hypersensitivity syndrome (AHS). Awareness and risk mitigation strategies are crucial for urologists managing patients on this medication.

Area of Science:

  • Urology
  • Pharmacology
  • Nephrology

Background:

  • Allopurinol is frequently prescribed for urinary stone prevention.
  • While generally safe, it carries risks of serious adverse events, notably Allopurinol hypersensitivity syndrome (AHS).
  • Increasing incidence of uric acid stones necessitates greater awareness of allopurinol's side effects.

Purpose of the Study:

  • To review potential adverse effects of allopurinol.
  • To present findings from a literature review on Allopurinol hypersensitivity syndrome (AHS).
  • To identify high-risk patients, discuss genetic testing, and provide management guidelines.

Main Methods:

  • Comprehensive literature review on allopurinol adverse effects.
  • Focused review of current literature specifically on Allopurinol hypersensitivity syndrome (AHS).

Related Experiment Videos

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.6K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.1K
  • Analysis of patient risk factors, genetic susceptibility, and best practice guidelines.

    • Main Results:

    • Allopurinol, though common for stone prevention, has potential severe side effects.
    • Allopurinol hypersensitivity syndrome (AHS) is a rare but life-threatening complication.
    • Identification of at-risk populations and available genetic testing for susceptibility.

    Conclusions:

    • Urologists must be aware of allopurinol's adverse events, especially AHS.
    • Risk mitigation strategies and understanding genetic predispositions are key for safe allopurinol use.
    • Guidance is provided for considering allopurinol therapy and managing potential complications.